Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Y Gulenchyn

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Clinical Nuclear Medicine|January 1, 1987
Technetium-99m MDP scintigraphy. An insensitive tool for the detection of bone marrow metastasesK Y Gulenchyn, W Papoff
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1986
Splenic hemangioma presenting as a "hot spot" on radiocolloid scintigraphyK Y Gulenchyn, M R Dover, S Kelly
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|January 1, 1989
Routine determination of radiochemical purity of 99mTc-MIBIA Proulx, J R Ballinger, K Y Gulenchyn
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|January 1, 1987
Technetium-99m diethyldithiocarbamate (DDC): comparison with thallium-201 DDC as an agent for brain imagingJ R Ballinger, B Gerson, K Y Gulenchyn
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1989
Technetium-99m dithiocarbamates as potential brain agents: evaluation of aliphatic and amine-containing analoguesJ R Ballinger, B Gerson, K Y Gulenchyn
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1988
Technetium-99m HM-PAO stereoisomers: differences in interaction with glutathioneJ R Ballinger, R H Reid, K Y Gulenchyn
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1989
Clinical use of technetium-99m HM-PAO for determination of brain deathR H Reid, K Y Gulenchyn, J R Ballinger
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1990
Radiopharmaceutical factors in the variable quality of [99mTc]HM-PAO images of the brainJ R Ballinger, K Y Gulenchyn, R H Reid
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|January 1, 1989
Technetium-99m spiperone dithiocarbamate: a potential radiopharmaceutical for dopamine receptor imaging with SPECTJ R Ballinger, K Y Gulenchyn, M N Hassan
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1990
A kit for labelling erythrocytes or leukocytes with technetium-99mA Proulx, B Gerson, J R Ballinger, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Clinical Nuclear Medicine|January 1, 1987
Technetium-99m MDP scintigraphy. An insensitive tool for the detection of bone marrow metastasesK Y Gulenchyn, W Papoff
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1986
Splenic hemangioma presenting as a "hot spot" on radiocolloid scintigraphyK Y Gulenchyn, M R Dover, S Kelly
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|January 1, 1989
Routine determination of radiochemical purity of 99mTc-MIBIA Proulx, J R Ballinger, K Y Gulenchyn
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|January 1, 1987
Technetium-99m diethyldithiocarbamate (DDC): comparison with thallium-201 DDC as an agent for brain imagingJ R Ballinger, B Gerson, K Y Gulenchyn
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1989
Technetium-99m dithiocarbamates as potential brain agents: evaluation of aliphatic and amine-containing analoguesJ R Ballinger, B Gerson, K Y Gulenchyn
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1988
Technetium-99m HM-PAO stereoisomers: differences in interaction with glutathioneJ R Ballinger, R H Reid, K Y Gulenchyn
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1989
Clinical use of technetium-99m HM-PAO for determination of brain deathR H Reid, K Y Gulenchyn, J R Ballinger
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1990
Radiopharmaceutical factors in the variable quality of [99mTc]HM-PAO images of the brainJ R Ballinger, K Y Gulenchyn, R H Reid
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|January 1, 1989
Technetium-99m spiperone dithiocarbamate: a potential radiopharmaceutical for dopamine receptor imaging with SPECTJ R Ballinger, K Y Gulenchyn, M N Hassan
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1990
A kit for labelling erythrocytes or leukocytes with technetium-99mA Proulx, B Gerson, J R Ballinger, et al.
Pageof 3